New blood clot drug put to the test in healthy volunteers
Knowledge-focused
Completed
This early-stage study looked at how a new drug called VMX-C001 interacts with common blood thinners (heparin and rivaroxaban) in 16 healthy adults. Researchers measured changes in blood clotting times to understand the drug's effects. The goal was to gather safety and activity d…
Phase: PHASE1 • Sponsor: VarmX B.V. • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC